{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:57:15Z","timestamp":1792270635983,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11060-026-05520-8","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:16:07Z","timestamp":1774523767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cerebrospinal fluid ctDNA as a prognostic and disease-activity biomarker in leptomeningeal metastases: systematic review, meta-analysis, and implications for CSF-guided care"],"prefix":"10.1007","volume":"177","author":[{"given":"Baradwaj Simha","family":"Sankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Antwi","family":"Boasiako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Padova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"6","key":"5520_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1055\/s-0043-1776996","volume":"43","author":"R Malani","year":"2023","unstructured":"Malani R, Bhatia A, Warner AB, Yang JT (2023) Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers. Semin Neurol 43(6):859\u2013866. https:\/\/doi.org\/10.1055\/s-0043-1776996","journal-title":"Semin Neurol"},{"issue":"42","key":"5520_CR2","doi-asserted-by":"publisher","first-page":"73312","DOI":"10.18632\/oncotarget.20272","volume":"8","author":"G Nayar","year":"2017","unstructured":"Nayar G, Ejikeme T, Chongsathidkiet P et al (2017) Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget 8(42):73312\u201373328. https:\/\/doi.org\/10.18632\/oncotarget.20272","journal-title":"Oncotarget"},{"key":"5520_CR3","doi-asserted-by":"publisher","first-page":"116706","DOI":"10.1016\/j.jns.2020.116706","volume":"411","author":"JP Thakkar","year":"2020","unstructured":"Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV (2020) Leptomeningeal metastasis from solid tumors. J Neurol Sci 411:116706. https:\/\/doi.org\/10.1016\/j.jns.2020.116706","journal-title":"J Neurol Sci"},{"issue":"2","key":"5520_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-008-9758-3","volume":"93","author":"F Waki","year":"2009","unstructured":"Waki F, Ando M, Takashima A et al (2009) Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93(2):205\u2013212. https:\/\/doi.org\/10.1007\/s11060-008-9758-3","journal-title":"J Neurooncol"},{"issue":"8","key":"5520_CR5","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/cncr.21322","volume":"104","author":"T Seute","year":"2005","unstructured":"Seute T, Leffers P, ten Velde GPM, Twijnstra A (2005) Leptomeningeal metastases from small cell lung carcinoma. Cancer 104(8):1700\u20131705. https:\/\/doi.org\/10.1002\/cncr.21322","journal-title":"Cancer"},{"issue":"18","key":"5520_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JL Clarke","year":"2010","unstructured":"Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74(18):1449\u20131454. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1a69","journal-title":"Neurology"},{"issue":"4","key":"5520_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.46883\/2025.25921040","volume":"39","author":"M Kesireddy","year":"2025","unstructured":"Kesireddy M, Marar R, Samson K, Shonka N (2025) Utility of the Diagnosis-Specific Graded Prognostic Assessment for Prognostication in Leptomeningeal Disease. Oncol Williston Park N 39(4):141\u2013147. https:\/\/doi.org\/10.46883\/2025.25921040","journal-title":"Oncol Williston Park N"},{"key":"5520_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","volume":"56","author":"JW Hyun","year":"2016","unstructured":"Hyun JW, Jeong IH, Joung A, Cho HJ, Kim SH, Kim HJ (2016) Leptomeningeal metastasis: Clinical experience of 519 cases. Eur J Cancer Oxf Engl 1990 56:107\u2013114. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.021","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"5520_CR9","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3389\/fimmu.2019.01713","volume":"10","author":"M Schulz","year":"2019","unstructured":"Schulz M, Salamero-Boix A, Niesel K, Alekseeva T, Sevenich L (2019) Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis. Front Immunol 10:1713. https:\/\/doi.org\/10.3389\/fimmu.2019.01713","journal-title":"Front Immunol"},{"issue":"1","key":"5520_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaoncol.2024.5218","volume":"11","author":"J Malhotra","year":"2025","unstructured":"Malhotra J, Mambetsariev I, Gilmore G et al (2025) Targeting CNS Metastases in Non\u2013Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A Review. JAMA Oncol 11(1):60. https:\/\/doi.org\/10.1001\/jamaoncol.2024.5218","journal-title":"JAMA Oncol"},{"issue":"1","key":"5520_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","volume":"20","author":"A Boire","year":"2020","unstructured":"Boire A, Brastianos PK, Garzia L, Valiente M (2020) Brain metastasis. Nat Rev Cancer 20(1):4\u201311. https:\/\/doi.org\/10.1038\/s41568-019-0220-y","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"5520_CR12","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.3390\/cancers13122888","volume":"13","author":"A Pellerino","year":"2021","unstructured":"Pellerino A, Brastianos PK, Rud\u00e0 R, Soffietti R (2021) Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches. Cancers 13(12):2888. https:\/\/doi.org\/10.3390\/cancers13122888","journal-title":"Cancers"},{"issue":"3","key":"5520_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11060-023-04520-2","volume":"165","author":"Q Miao","year":"2023","unstructured":"Miao Q, Zheng X, Li L et al (2023) Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. J Neurooncol 165(3):517\u2013525. https:\/\/doi.org\/10.1007\/s11060-023-04520-2","journal-title":"J Neurooncol"},{"issue":"1","key":"5520_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1078-0432.CCR-17-1582","volume":"24","author":"Y Fan","year":"2018","unstructured":"Fan Y, Zhu X, Xu Y et al (2018) Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non-Small Cell Lung Cancer. Clin Cancer Res Off J Am Assoc Cancer Res 24(1):209\u2013216. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1582","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"5520_CR15","doi-asserted-by":"publisher","first-page":"104674","DOI":"10.1016\/j.breast.2025.104674","volume":"85","author":"PH Wessels","year":"2026","unstructured":"Wessels PH, Cornelissen S, Monkhorst K et al (2026) Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases. Breast 85:104674. https:\/\/doi.org\/10.1016\/j.breast.2025.104674","journal-title":"Breast"},{"issue":"10","key":"5520_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/neuonc\/noae103","volume":"26","author":"JA Wilcox","year":"2024","unstructured":"Wilcox JA, Chukwueke UN, Ahn MJ et al (2024) Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Neuro-Oncol 26(10):1781\u20131804. https:\/\/doi.org\/10.1093\/neuonc\/noae103","journal-title":"Neuro-Oncol"},{"issue":"1","key":"5520_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM (1995) Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38(1):51\u201357. https:\/\/doi.org\/10.1002\/ana.410380111","journal-title":"Ann Neurol"},{"issue":"1","key":"5520_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","volume":"29","author":"G Ozcan","year":"2023","unstructured":"Ozcan G, Singh M, Vredenburgh JJ (2023) Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments. Clin Cancer Res Off J Am Assoc Cancer Res 29(1):11\u201329. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1585","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"5520_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-025-01412-y","volume":"25","author":"U Sener","year":"2025","unstructured":"Sener U, Wilcox JA, Boire AA (2025) Leptomeningeal Disease: Current Approaches and Future Directions. Curr Neurol Neurosci Rep 25(1):25. https:\/\/doi.org\/10.1007\/s11910-025-01412-y","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Suppl 5","key":"5520_CR20","doi-asserted-by":"publisher","first-page":"v86","DOI":"10.1093\/noajnl\/vdab108","volume":"3","author":"U Sener","year":"2021","unstructured":"Sener U, Kumthekar P, Boire A (2021) Advances in the diagnosis, evaluation, and management of leptomeningeal disease. Neuro-Oncol Adv 3(Suppl 5):v86\u2013v95. https:\/\/doi.org\/10.1093\/noajnl\/vdab108","journal-title":"Neuro-Oncol Adv"},{"issue":"3","key":"5520_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11060-023-04519-9","volume":"165","author":"JH Wijaya","year":"2023","unstructured":"Wijaya JH, Patel UD, Quintero-Consuegra MD et al (2023) Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis. J Neurooncol 165(3):431\u2013438. https:\/\/doi.org\/10.1007\/s11060-023-04519-9","journal-title":"J Neurooncol"},{"issue":"2","key":"5520_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1227\/neu.0000000000001982","volume":"91","author":"JT McMahon","year":"2022","unstructured":"McMahon JT, Studer M, Ulrich B et al (2022) Circulating Tumor DNA in Adults With Glioma: A Systematic Review and Meta-Analysis of Biomarker Performance. Neurosurgery 91(2):231\u2013238. https:\/\/doi.org\/10.1227\/neu.0000000000001982","journal-title":"Neurosurgery"},{"issue":"6","key":"5520_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.annonc.2025.02.005","volume":"36","author":"S Cabezas-Camarero","year":"2025","unstructured":"Cabezas-Camarero S, P\u00e9rez-Alfayate R, Garc\u00eda-Barber\u00e1n V et al (2025) ctDNA detection in cerebrospinal fluid and plasma and mutational concordance with the primary tumor in a multicenter prospective study of patients with glioma. Ann Oncol Off J Eur Soc Med Oncol 36(6):660\u2013672. https:\/\/doi.org\/10.1016\/j.annonc.2025.02.005","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"5520_CR24","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1038\/s41467-020-19175-0","volume":"11","author":"L Escudero","year":"2020","unstructured":"Escudero L, Llort A, Arias A et al (2020) Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma. Nat Commun 11(1):5376. https:\/\/doi.org\/10.1038\/s41467-020-19175-0","journal-title":"Nat Commun"},{"issue":"6","key":"5520_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-21-3017","volume":"28","author":"A Fitzpatrick","year":"2022","unstructured":"Fitzpatrick A, Iravani M, Mills A et al (2022) Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis. Clin Cancer Res 28(6):1180\u20131191. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3017","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5520_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1158\/1078-0432.CCR-22-2434","volume":"29","author":"NA Wijetunga","year":"2023","unstructured":"Wijetunga NA, Goglia AG, Weinhold N et al (2023) Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases. Clin Cancer Res 29(4):775\u2013783. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2434","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5520_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11060-023-04487-0","volume":"166","author":"S Arjuna","year":"2024","unstructured":"Arjuna S, Shah M, Dono A et al (2024) Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer. J Neurooncol 166(1):39\u201349. https:\/\/doi.org\/10.1007\/s11060-023-04487-0","journal-title":"J Neurooncol"},{"issue":"1","key":"5520_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00432-020-03324-5","volume":"147","author":"W Choi","year":"2021","unstructured":"Choi W, Cho Y, Park SY, Hwang KH, Han JY, Lee Y (2021) A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis. J Cancer Res Clin Oncol 147(1):213\u2013222. https:\/\/doi.org\/10.1007\/s00432-020-03324-5","journal-title":"J Cancer Res Clin Oncol"},{"issue":"24","key":"5520_CR29","doi-asserted-by":"publisher","first-page":"e40703","DOI":"10.1016\/j.heliyon.2024.e40703","volume":"10","author":"L Li","year":"2024","unstructured":"Li L, Huang Z, Chen Y et al (2024) Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 10(24):e40703. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40703","journal-title":"Heliyon"},{"issue":"4","key":"5520_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdy009","volume":"29","author":"YS Li","year":"2018","unstructured":"Li YS, Jiang BY, Yang JJ et al (2018) Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy. Ann Oncol Off J Eur Soc Med Oncol 29(4):945\u2013952. https:\/\/doi.org\/10.1093\/annonc\/mdy009","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"5520_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.lungcan.2023.02.005","volume":"178","author":"E Miao","year":"2023","unstructured":"Miao E, Eichholz JE, Lebow ES et al (2023) Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib. Lung Cancer 178:57\u201365. https:\/\/doi.org\/10.1016\/j.lungcan.2023.02.005","journal-title":"Lung Cancer"},{"issue":"12","key":"5520_CR32","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/1878-0261.12574","volume":"13","author":"S Villatoro","year":"2019","unstructured":"Villatoro S, Mayo-de\u2010las\u2010Casas C, Jordana\u2010Ariza N et al (2019) Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions. Mol Oncol 13(12):2633\u20132645. https:\/\/doi.org\/10.1002\/1878-0261.12574","journal-title":"Mol Oncol"},{"issue":"5","key":"5520_CR33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00432-022-04053-7","volume":"149","author":"Y Wang","year":"2023","unstructured":"Wang Y, Luo N, Gao Y et al (2023) The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer. J Cancer Res Clin Oncol 149(5):1679\u20131690. https:\/\/doi.org\/10.1007\/s00432-022-04053-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"5520_CR34","doi-asserted-by":"publisher","first-page":"e2120040","DOI":"10.1001\/jamanetworkopen.2021.20040","volume":"4","author":"MD White","year":"2021","unstructured":"White MD, Klein RH, Shaw B et al (2021) Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid. JAMA Netw Open 4(8):e2120040. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.20040","journal-title":"JAMA Netw Open"},{"issue":"5","key":"5520_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jtho.2019.01.007","volume":"14","author":"MM Zheng","year":"2019","unstructured":"Zheng MM, Li YS, Jiang BY et al (2019) Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC. J Thorac Oncol 14(5):924\u2013932. https:\/\/doi.org\/10.1016\/j.jtho.2019.01.007","journal-title":"J Thorac Oncol"},{"issue":"1","key":"5520_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-022-02387-0","volume":"20","author":"MM Zheng","year":"2022","unstructured":"Zheng MM, Li YS, Tu HY et al (2022) Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases. BMC Med 20(1):197. https:\/\/doi.org\/10.1186\/s12916-022-02387-0","journal-title":"BMC Med"},{"key":"5520_CR37","doi-asserted-by":"publisher","unstructured":"Leite da Silva LFS, Erick F, de Menezes R, Buonopane IR, de Souza, Erito M, de Menezes (2025) Caio Ulysses Galvani; Lopes, Gilberto. Plasma ctDNA kinetics as a predictor of systemic therapy response for advanced non-small cell lung cancer: a systematic review and meta-analysis. The oncologist. 30(2). https:\/\/doi.org\/10.1093\/oncolo\/oyae344","DOI":"10.1093\/oncolo\/oyae344"},{"issue":"1","key":"5520_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades A, Ouwens MJ, Welton NJ (2012) Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 12(1):9. https:\/\/doi.org\/10.1186\/1471-2288-12-9","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"5520_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","journal-title":"Biometrics"},{"issue":"7109","key":"5520_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"issue":"10","key":"5520_CR41","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","volume":"61","author":"JL Peters","year":"2008","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10):991\u2013996. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.010","journal-title":"J Clin Epidemiol"},{"key":"5520_CR42","unstructured":"McGuinness LA (2021) In: Harrer M, Cuijpers P, Furukawa TA, Ebert DD (eds) Doing Meta-Analysis with R: A Hands-On Guide. Springer. https:\/\/bookdown.org\/MathiasHarrer\/Doing_Meta_Analysis_in_R\/rob-plots.html"},{"key":"5520_CR43","unstructured":"R Core Team (2025) R: A language and environment for statistical computing. R foundation for statistical computing. https:\/\/www.R-project.org\/"},{"issue":"2","key":"5520_CR44","doi-asserted-by":"publisher","first-page":"e13733","DOI":"10.1111\/crj.13733","volume":"18","author":"D Geng","year":"2024","unstructured":"Geng D, Niu R, Li J et al (2024) EGFR amplification indicated poor prognosis in EGFR-mutated lung cancer with leptomeningeal metastases. Clin Respir J 18(2):e13733. https:\/\/doi.org\/10.1111\/crj.13733","journal-title":"Clin Respir J"},{"issue":"2","key":"5520_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jtho.2020.10.008","volume":"16","author":"MM Zheng","year":"2021","unstructured":"Zheng MM, Li YS, Tu HY et al (2021) Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC. J Thorac Oncol 16(2):250\u2013258. https:\/\/doi.org\/10.1016\/j.jtho.2020.10.008","journal-title":"J Thorac Oncol"},{"key":"5520_CR46","doi-asserted-by":"publisher","first-page":"664420","DOI":"10.3389\/fonc.2022.664420","volume":"12","author":"X Wu","year":"2022","unstructured":"Wu X, Xing P, Shi M et al (2022) Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases. Front Oncol 12:664420. https:\/\/doi.org\/10.3389\/fonc.2022.664420","journal-title":"Front Oncol"},{"issue":"5","key":"5520_CR47","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/neuonc\/noz208","volume":"22","author":"KS Nevel","year":"2020","unstructured":"Nevel KS, DiStefano N, Lin X et al (2020) A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer. Neuro-Oncol 22(5):675\u2013683. https:\/\/doi.org\/10.1093\/neuonc\/noz208","journal-title":"Neuro-Oncol"},{"issue":"1","key":"5520_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12967-023-04077-8","volume":"21","author":"X Chen","year":"2023","unstructured":"Chen X, Bai K, Zhang Y et al (2023) Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer. J Transl Med 21(1):296. https:\/\/doi.org\/10.1186\/s12967-023-04077-8","journal-title":"J Transl Med"},{"issue":"1","key":"5520_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-023-04471-8","volume":"165","author":"K Bai","year":"2023","unstructured":"Bai K, Chen X, Qi X et al (2023) Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. J Neurooncol 165(1):149\u2013160. https:\/\/doi.org\/10.1007\/s11060-023-04471-8","journal-title":"J Neurooncol"},{"issue":"11","key":"5520_CR50","doi-asserted-by":"publisher","first-page":"937","DOI":"10.21037\/atm-21-1249","volume":"9","author":"H Xu","year":"2021","unstructured":"Xu H, Chen H, Kong J et al (2021) Osimertinib for the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer patients with leptomeningeal metastases and different T790M status. Ann Transl Med 9(11):937\u2013937. https:\/\/doi.org\/10.21037\/atm-21-1249","journal-title":"Ann Transl Med"},{"key":"5520_CR51","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.neo.2024.101113","volume":"60","author":"SK Liang","year":"2025","unstructured":"Liang SK, Liao WY, Shih JY et al (2025) Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia N Y N 60:101113. https:\/\/doi.org\/10.1016\/j.neo.2024.101113","journal-title":"Neoplasia N Y N"},{"key":"5520_CR52","doi-asserted-by":"publisher","first-page":"902664","DOI":"10.3389\/fonc.2022.902664","volume":"12","author":"H Yang","year":"2022","unstructured":"Yang H, Wen L, Zhao C et al (2022) EGFR amplification is a putative resistance mechanism for NSCLC\u2013LM patients with TKI therapy and is associated with poor outcome. Front Oncol 12:902664. https:\/\/doi.org\/10.3389\/fonc.2022.902664","journal-title":"Front Oncol"},{"issue":"20","key":"5520_CR53","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.3390\/cancers14205028","volume":"14","author":"P Wang","year":"2022","unstructured":"Wang P, Zhang Q, Han L et al (2022) Genomic Instability in Cerebrospinal Fluid Cell-Free DNA Predicts Poor Prognosis in Solid Tumor Patients with Meningeal Metastasis. Cancers 14(20):5028. https:\/\/doi.org\/10.3390\/cancers14205028","journal-title":"Cancers"},{"issue":"1","key":"5520_CR54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12885-022-09597-y","volume":"22","author":"H Yang","year":"2022","unstructured":"Yang H, Wen L, Pan Y et al (2022) Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC Cancer 22(1):580. https:\/\/doi.org\/10.1186\/s12885-022-09597-y","journal-title":"BMC Cancer"},{"issue":"5","key":"5520_CR55","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/s41591-025-03538-5","volume":"31","author":"MM Zheng","year":"2025","unstructured":"Zheng MM, Zhou Q, Chen HJ et al (2025) Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases. Nat Med 31(5):1547\u20131556. https:\/\/doi.org\/10.1038\/s41591-025-03538-5","journal-title":"Nat Med"},{"issue":"14","key":"5520_CR56","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/1759-7714.14866","volume":"14","author":"C Chiang","year":"2023","unstructured":"Chiang C, Ho H, Yeh Y et al (2023) Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non\u2010small\u2010cell lung cancer patients with leptomeningeal metastases. Thorac Cancer 14(14):1251\u20131259. https:\/\/doi.org\/10.1111\/1759-7714.14866","journal-title":"Thorac Cancer"},{"issue":"2","key":"5520_CR57","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/S1470-2045(24)00430-3","volume":"26","author":"J Fares","year":"2025","unstructured":"Fares J, Petrosyan E, Dmello C, Lukas RV, Stupp R, Lesniak MS (2025) Rethinking metastatic brain cancer as a CNS disease. Lancet Oncol 26(2):e111\u2013e121. https:\/\/doi.org\/10.1016\/S1470-2045(24)00430-3","journal-title":"Lancet Oncol"},{"issue":"27","key":"5520_CR58","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1038\/s41388-025-03315-1","volume":"44","author":"AM Powell","year":"2025","unstructured":"Powell AM, Watson L, Luzietti L, Prekovic S, Young LS, Vare\u0161lija D (2025) The epigenetic landscape of brain metastasis. Oncogene 44(27):2227\u20132239. https:\/\/doi.org\/10.1038\/s41388-025-03315-1","journal-title":"Oncogene"},{"issue":"4","key":"5520_CR59","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/nan.12691","volume":"47","author":"AB D\u00edaz M\u00e9ndez","year":"2021","unstructured":"D\u00edaz M\u00e9ndez AB, Tremante E, Regazzo G, Brandner S, Rizzo MG (2021) Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers. Neuropathol Appl Neurobiol 47(4):471\u2013487. https:\/\/doi.org\/10.1111\/nan.12691","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"5520_CR60","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1200\/JCO.22.00826","volume":"41","author":"JA Mutter","year":"2023","unstructured":"Mutter JA, Alig SK, Esfahani MS et al (2023) Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas. J Clin Oncol Off J Am Soc Clin Oncol 41(9):1684\u20131694. https:\/\/doi.org\/10.1200\/JCO.22.00826","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05520-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:16:24Z","timestamp":1778224584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05520-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5520"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05520-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}